| Section 1: General Principles | 1 | |
| 1. Pharmacokinetics and Pharmacodynamics | 1 | |
| 2. Drug Transport/Drug Transporters | 41 | |
| 3. Drug Metabolism | 71 | |
| 4. Pharmacogenomics | 93 | |
| 5. Principles of Therapeutics | 117 | |
| Section 2: Drugs Acting at Synaptic and Neuroeffector Junctional Sites | 137 | |
| 6. Neurotransmission: The Autonomic and Somatic Motor Nervous Systems | 137 | |
| 7. Muscarinic Receptor Agonists and Antagonists | 183 | |
| 8. Anticholinesterase Agents | 201 | |
| 9. Agents Acting at the Neuromuscular Junction and Autonomic Ganglia | 217 | |
| 10. Catecholamines, Sympathomimetic Drugs, and Adrenergic Receptor Antagonists | 237 | |
| 11. 5-Hydroxytryptamine (Serotonin) Receptor Agonists and Antagonists | 297 | |
| Section 3: Drugs Acting on the Central Nervous System | 317 | |
| 12. Neurotransmission and the Central Nervous System | 317 | |
| 13. History and Principles of Anesthesiology; General Anesthetics | 341 | |
| 14. Local Anesthetics | 369 | |
| 15. The Therapeutic Gases: Oxygen, Carbon Dioxide, Nitric Oxide, and Helium | 387 | |
| 16. Hypnotics and Sedatives | 401 | |
| 17. Introduction to Psychopharmacology: Drug Therapy of Depression and Anxiety Disorders | 429 | |
| 18. Pharmacotherapy of Psychosis and Mania | 461 | |
| 19. Drugs Effective in the Therapy of the Epilepsies | 501 | |
| 20. Treatment of Central Nervous System Degenerative Disorders | 527 | |
| 21. Opioid Analgesics | 547 | |
| 22. Ethanol | 591 | |
| 23. Drug Addiction and Drug Abuse | 607 | |
| Section 4: Autacoids: Drug therapy of Inflammation | 629 | |
| 24. Histamine, Bradykinin, and Their Antagonists | 629 | |
| 25. Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor | 653 | |
| 26. Analgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout | 671 | |
| 27. Drugs Used in the Treatment of Asthma | 717 | |
| Section 5: Drugs Affecting Renal and Cardiovascular Function | 737 | |
| 28. Diuretics | 737 | |
| 29. Vasopressin and Other Agents Affecting the Renal Conservation of Water | 771 | |
| 30. Renin and Angiotensin | 789 | |
| 31. Drugs Used for the Treatment of Myocardial Ischemia | 823 | |
| 32. Antihypertensive Agents and the Drug Therapy of Hypertension | 845 | |
| 33. Pharmacological Treatment of Heart Failure | 869 | |
| 34. Antiarrhythmic Drugs | 899 | |
| 35. Drug Therapy for Hypercholesterolemia and Dyslipidemia | 933 | |
| Section 6: Drugs Affecting Gastrointestinal Function | 967 | |
| 36. Agents Used for Control of Gastric Acidity and Treatment of Peptic Ulcers and Gastroesopheageal Reflux Disease | 967 | |
| 37. Prokinetic Agents, Antiemetics, and Agents Used in Irritable Bowel Syndrome | 983 | |
| 38. Agents Used of Diarrhea, Constipation, and Inflammatory Bowel Disease; Agents Used for Biliary and Pancreatic Disease | 1009 | |
| Section 7: Chemotherapy of Parasitic Infections | 1021 | |
| 39. Drugs Used in the Chemotherapy of Protozoal Infections: Malaria |
1021 | |
| 40. Drugs Used in the Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections |
1049 | |
| 41. Drugs Used in the Chemotherapy of Helminthiasis | 1073 | |
| Section 8: Chemotherapy of Microbial Diseases | 1095 | |
| 42. General Considerations | 1095 | |
| 43. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections | 1111 | |
| 44. Penicillins, Cephalosporins, and Other b-Lactam Antibiotics | 1127 | |
| 45. The Aminoglycosides | 1155 | |
| 46. Protein-Synthesis Inhibitors and Miscellaneous Antibacterial Agents | 1173 | |
| 47. Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy | 1203 | |
| 48. Antifungal Agents | 1225 | |
| 49. Antiviral Agents (Nonretroviral) | 1243 | |
| 50. Antiretroviral Agents | 1273 | |
| Section 9: Chemotherapy of Neoplastic Diseases | 1315 | |
| 51. Antineoplastic Agents | 1315 | |
| Section 10: Drugs Used for Immunomodulation | 1405 | |
| 52. Imunomodulators: Immunosuppressive Agents, Tolerogens, and Immunostimulants | 1405 | |
| Section 11: Drugs Acting on the Blood and the Blood-Forming Organs | 1433 | |
| 53. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins | 1433 | |
| 54. Blood Coagulation and Anticoagulant, Thrombolytic, and Antiplatelet Drugs | 1467 | |
| Section 12: Hormones and hormone Antagonists | 1489 | |
| 55. Pituitary Hormones and Their Hypothalamic Releasing Factors | 1489 | |
| 56. Thyroid and Antithyroid Drugs | 1511 | |
| 57. Estrogens and Progestins | 1545 | |
| 58. Androgens | 1573 | |
| 59. Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogs; Inhibitors of the Synthesis and Actions of Adrenocortical Hormones |
1587 | |
| 60. Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas | 1613 | |
| 61. Agents Affecting Calcification and Bone Turnover: Calcium, Phosphate, Parathyroid Hormone, Vitamin D, Calcitonin, and Other Compounds |
1647 | |
| Section 13: Dermatology | 1679 | |
| 62. Dermatological Pharmacology | 1679 | |
| Section 14: Ophthalmology | 1707 | |
| 63. Ocular Pharmacology | 1707 | |
| Section 15: Toxicology | 1739 | |
| 64. Principles of Toxicology; Treatment of Poisoning | 1739 | |
| 65. Poisoning; Heavy Metals and Heavy-Metal Antagonists | 1753 | |
| Appendices | 1777 | |
| Principles of Prescription Order Writing and Patient Compliance | 1777 | |
| Disign and Optimization of Dosage Regimens; Pharmacokinetic Data | 1787 | |
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
| 関連記事 | 「IS」 |
.